For type 2 diabetes, NICE guidance recommends reviewing GLP-1 therapy at 6 months, continuing only if HbA1c has reduced by at least 11 mmol/mol (1.0%) and weight has decreased by at least 3% of initial body weight
2 While physicians are excited to have an effective tool for patients struggling with obesity, many are concerned with the long-term use of these drugs, noting side effects and cost are top reasons for patients who discontinue treatment
the longer-term effect is pressure on local retail pricing and insurance formulary policies
Typically, UTIs can be treated with an antibiotic
This hormone helps regulate blood sugar, slows how quickly the stomach empties, and sends signals to the brain that contribute to feeling full
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects